Explained: What is the new XFG variant detected in India amid rising Covid cases?

A newly emerging strain called 'XFG' has now been detected in India, with the Covid-19 case tally surpassing 6,500. According to Insacog, the government agency monitoring the different variants, as many as 163 cases of the XFG variant have been reported in India so far, with the most from Maharashtra (89). Is there a reason to worry? read more
According to the Insacog, 163 cases of the XFG variant have been reported across India so far. Image for Representation. Pixabay
India is once again seeing a rise in Covid-19 cases, and this time, a new sub-variant is also in the mix.
While the JN.1 variant of Omicron has been around for a while, a newly emerging strain called 'XFG' has now been detected in the country, raising fresh concerns as infections are creeping up again.
According to the Indian SARS-CoV-2 Genomics Consortium (Insacog), which monitors how the virus which causes Covid-19 evolves, as many as 163 cases of the XFG variant have been reported across India so far.
STORY CONTINUES BELOW THIS AD
This rise in cases comes alongside a steady climb in active infections across the country.
According to the Union Health Ministry, India has now recorded over 6,500 active Covid-19 cases, with 769 new cases reported in just the last 48 hours.
So, what exactly is this XFG variant? And does it pose a serious threat? Are vaccines effective against the new variant? Here's what we know so far
Covid-19 in India: What is the XFG variant?
The XFG variant is a recombinant subvariant of the SARS-CoV-2 virus—essentially, it's the result of two earlier strains, LF.7 and LP.8.1.2, merging together.
Recombinant variants like XFG typically emerge when someone is infected with two different versions of the virus at the same time, allowing the virus to 'mix and match' its genetic code.
The XFG variant is a recombinant subvariant of the SARS-CoV-2 virus—essentially, it's the result of two earlier strains, LF.7 and LP.8.1.2, merging together. Representational Image
According to The Lancet journal, XFG falls under the Omicron family of Covid-19 variants, which has been the dominant global strain since late 2021. It was first detected in Canada.
The study also points out that the XFG variant shows 'strong immune evasion'—meaning it has the ability to dodge the body's natural immune defences, helping it survive longer and spread more easily.
Where are the XFG cases in India?
The latest data from Insacog shows that India has reported 163 cases of the XFG variant so far.
Maharashtra has recorded the highest number with 89 cases, followed by Tamil Nadu (16), Kerala (15), Gujarat (11), and Andhra Pradesh, Madhya Pradesh, and West Bengal, each with six cases.
STORY CONTINUES BELOW THIS AD
Telangana is the newest state on the list, with one confirmed case.
The latest data from Insacog shows that India has reported 163 cases of the XFG variant so far. Maharashtra has recorded the highest number of the XFG variant with 89 cases. Image for Representation/ PTI
Most of these infections—159 cases—were detected in May 2024, while two each were reported in April and June.
Is there a reason to worry?
For now, the answer seems to be no.
There is currently no evidence suggesting that the XFG variant causes more severe illness or leads to higher death rates compared to other Omicron sub-variants.
As with most strains that evolved from Omicron, XFG is mostly associated with mild upper respiratory symptoms, particularly in people who are vaccinated or have previously recovered from Covid-19.
So far, XFG has not been labelled a Variant of Concern (VOC) or Variant of Interest (VOI) by either the World Health Organisation (WHO) or India's Ministry of Health. That means it hasn't been linked to serious outbreaks, a rise in hospitalisations, or issues with vaccine effectiveness—at least not yet.
That said, health experts remain cautious.
The virus is still evolving, and variants that evade immunity or develop mutations that improve their ability to bind to human cells (especially through the spike protein) could cause future waves if not closely watched.
STORY CONTINUES BELOW THIS AD
There is currently no evidence suggesting that the XFG variant causes more severe illness or leads to higher death rates compared to other Omicron sub-variants. Image for Representation. AFP
'According to Indian Council of Medical Research (ICMR) data, 66 per cent of current respiratory viral infections in India are Covid-related. However, hospitalisation is low, including in Telangana. People with two or more comorbidities, weakened immunity, or above 70 years should remain alert,' Dr Kiran Madala, who is also a professor at Gandhi Medical College, told The Times of India.
Are vaccines effective against the XFG variant?
The good news is that India's current Covid-19 vaccines, including Covaxin, Covishield, and the newer booster shots, are still believed to provide protection against severe illness and hospitalisation from the XFG variant.
Health experts say that while mild breakthrough infections can still occur, especially as antibody levels decline over time, the T-cell immunity developed through vaccination is likely to stay effective.
Covid-19 cases cross the 6,500 mark
According to the Ministry of Health and Family Welfare, India's active Covid-19 cases have now surpassed 6,500, pointing to a steady uptick in infections.
The Ministry also confirmed 65 Covid-related deaths across Uttar Pradesh, West Bengal, Tamil Nadu, Punjab, Maharashtra, Madhya Pradesh, Kerala, Karnataka, Gujarat, and Delhi.
Kerala has emerged as the worst-hit state, with 1,957 active cases and seven new infections reported in just the last 24 hours. Amid the surge, the state government has made Covid-19 testing mandatory for individuals showing symptoms. They have also released updated guidelines, urging the public to take all necessary precautions.
STORY CONTINUES BELOW THIS AD
With input from agencies

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Business Standard

16 minutes ago

• Business Standard

Flu shot must as winter viruses may trigger heart attack or stroke: Study

People who are particularly vulnerable to a heart attack or stroke triggered by a respiratory virus are those with more than one of those traditional risk factors, especially older people The Conversation Winter is here, along with cold days and the inevitable seasonal surge in respiratory viruses. But it's not only the sniffles we need to worry about. Heart attacks and strokes also tend to rise during the winter months. In new research out this week we show one reason why. Our study shows catching common respiratory viruses raises your short-term risk of a heart attack or stroke. In other words, common viruses, such as those that cause flu and Covid, can trigger them. Wait, viruses can trigger heart attacks? Traditional risk factors such as smoking, high cholesterol, high blood pressure, diabetes, obesity and lack of exercise are the main reasons for heart attacks and strokes. And rates of heart attacks and strokes can rise in winter for a number of reasons. Factors such as low temperature, less physical activity, more time spent indoors – perhaps with indoor air pollutants – can affect blood clotting and worsen the effects of traditional risk factors. But our new findings build on those from other researchers to show how respiratory viruses can also be a trigger. The theory is respiratory virus infections set off a heart attack or stroke, rather than directly cause them. If traditional risk factors are like dousing a house in petrol, the viral infection is like the matchstick that ignites the flame. For healthy, young people, a newer, well-kept house is unlikely to spontaneously combust. But an older or even abandoned house with faulty electric wiring needs just a spark to lead to a blaze. People who are particularly vulnerable to a heart attack or stroke triggered by a respiratory virus are those with more than one of those traditional risk factors, especially older people. What we did and what we found Our team conducted a meta-analysis (a study of existing studies) to see which respiratory viruses play a role in triggering heart attacks and strokes, and the strength of the link. This meant studying more than 11,000 scientific papers, spanning 40 years of research. Overall, the influenza virus and SARS-CoV-2 (the virus that causes Covid) were the main triggers. If you catch the flu, we found the risk of a heart attack goes up almost 5.4 times and a stroke by 4.7 times compared with not being infected. The danger zone is short – within the first few days or weeks – and tapers off with time after being infected. Catching Covid can also trigger heart attacks and strokes, but there haven't been enough studies to say exactly what the increased risk is. We also found an increased risk of heart attacks or strokes with other viruses, including respiratory syncytial virus (RSV), enterovirus and cytomegalovirus. But the links are not as strong, probably because these viruses are less commonly detected or tested for. What's going on? Over a person's lifetime, our bodies wear and tear and the inside wall of our blood vessels becomes rough. Fatty build-ups (plaques) stick easily to these rough areas, inevitably accumulating and causing tight spaces. Generally, blood can still pass through, and these build-ups don't cause issues. Think of this as dousing the house in petrol, but it's not yet alight. So how does a viral infection act like a matchstick to ignite the flame? Through a cascading process of inflammation. High levels of inflammation that follow a viral infection can crack open a plaque. The body activates blood clotting to fix the crack but this clot could inadvertently block a blood vessel completely, causing a heart attack or stroke. Some studies have found fragments of the Covid virus inside the blood clots that cause heart attacks – further evidence to back our findings. We don't know whether younger, healthier people are also at increased risk of a heart attack or stroke after infection with a respiratory virus. That's because people in the studies we analysed were almost always older adults with at least one of those traditional risk factors, so were already vulnerable. The bad news is we will all be vulnerable eventually, just by getting older. What can we do about it? The triggers we identified are mostly preventable by vaccination. There is good evidence from clinical trials the flu vaccine can reduce the risk of a heart attack or stroke, especially if someone already has heart problems. We aren't clear exactly how this works. But the theory is that avoiding common infections, or having less severe symptoms, reduces the chances of setting off the inflammatory chain reaction. Covid vaccination could also indirectly protect against heart attacks and strokes. But the evidence is still emerging. Heart attacks and strokes are among Australia's biggest killers. If vaccinations could help reduce even a small fraction of people having a heart attack or stroke, this could bring substantial benefit to their lives, the community, our stressed health system and the economy. What should I do? At-risk groups should get vaccinated against flu and Covid. Pregnant women, and people over 60 with medical problems, should receive RSV vaccination to reduce their risk of severe disease. So if you are older or have predisposing medical conditions, check Australia's National Immunisation Program to see if you are eligible for a free vaccine. For younger people, a healthy lifestyle with regular exercise and balanced diet will set you up for life. Consider checking your heart age (a measure of your risk of heart disease), getting an annual flu vaccine and discuss Covid boosters with your GP.

Time of India

an hour ago

• Time of India

4 unusual symptoms of NB.1.8.1 COVID variant, which is spreading in the world

A new COVID-19 variant, NB.1.8.1 or 'Nimbus', is spreading globally, exhibiting unusual symptoms. Despite the scary-sounding symptoms, health authorities like the WHO and CDC continue to stress that the NB.1.8.1 variant doesn't cause more severe disease in most people. It is, however, highly transmissible—and that's what makes it a concern. A new COVID-19 variant named NB.1.8.1, or 'Nimbus', is making quiet but swift rounds across several parts of the world. It's not just the usual fatigue or fever that's troubling people; this time, it's something sharper, something more unexpected. While scientists confirm that this Omicron subvariant doesn't lead to more severe disease, what's catching global attention is its unusual presentation, symptoms that feel different from what earlier COVID waves showed. And that makes it even more important to know what signs to watch out for. Here are 4 surprising symptoms of the Nimbus variant that are creating a buzz among doctors and patients alike, along with the science behind what's real and what's just speculation. A sore throat that feels like razor blades Patients infected with the NB.1.8.1 variant have reported a sore throat so intense, they've likened it to 'swallowing glass' or 'razor blades.' Global health reports have confirmed that this sharp throat pain is indeed a defining symptom of the new variant. Unlike previous sore throats linked to Omicron or Delta, this one comes on fast and can be severely painful even with mild fever. This symptom may not indicate greater danger, but it does signal high infectivity. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Branded GLP-1 Medications: What Are Your Options? GoodRx Watch Now Undo The pain likely stems from the variant's increased ability to bind tightly to throat cells, making it a hotspot for early replication. Sudden loss of appetite One overlooked but increasingly reported sign is a sudden dip in appetite, even without nausea or stomach issues. This symptom isn't new to COVID-19, but in the case of Nimbus, it seems to come early and without other digestive complaints. It is suggested this could be due to inflammatory markers affecting the hypothalamus (the appetite control center in the brain), even before other symptoms surface. Loss of appetite and unexplained weight loss. A significant change in eating habits without any clear reason may be worth keeping an eye on, especially if paired with fatigue or body aches. Muscle aches in unusual areas Muscle pain isn't new, but in this wave, people have been experiencing soreness in odd spots—like the jaw, upper back, and even behind the ears. These aches could be linked to how this variant activates the immune system. NB.1.8.1 causes an early inflammatory reaction, especially in muscle groups that aren't usually affected by respiratory illnesses. It's not always full-body fatigue, sometimes, discomfort in specific muscles might be telling a bigger story. Irritating nasal congestion that lingers Persistent nasal stuffiness, described as 'never-ending congestion,' is another complaint that has stood out in NB.1.8.1 cases. Covid Is Back! U.S. Confirms New Chinese Variant Causing Surge; Lockdown In America, India Next? Is it different from a cold? Quite possibly. Patients have reported that usual decongestants don't work effectively, and the congestion feels heavier, sometimes lasting over a week. This could be due to longer viral shedding in the nasal passages caused by this specific subvariant. Unlike seasonal colds, this symptom tends to stay and can increase the risk of spreading the virus to others through sneezing or coughing. (This article is intended for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment) One step to a healthier you—join Times Health+ Yoga and feel the change

Mint

2 hours ago

• Mint

Covid-19 now endemic in India, say government scientists as cases decline

New Delhi: Covid-19 has become endemic in India, top scientists at the Department of Biotechnology (DBT) monitoring the virus have said, ruling out the risk of any severe fresh outbreak. The current situation, they noted, is marked by small, isolated episodes rather than large waves of infections. This assessment is reflected in the steadily declining number of active cases. India's active caseload dropped to 5,012 on Sunday, down from 5,976 on Friday, according to official data. Two new deaths were recorded in the last 24 hours, taking the total fatalities this year to 112. Scientists attribute the decline to high population immunity and the continuing mildness of the virus. The current spread is largely driven by Omicron sub-variants NB.1.8.1 and LF.7, which have so far remained less virulent. 'When transmission efficiency increases, the peak comes faster and the decline is also faster,' said Dr Raman Gangakhedkar, national chair at the Indian Council of Medical Research (ICMR) and former head scientist at the agency. 'Covid-19 has become endemic in India. The concerning part is that we don't want new infections, but the good news is that new variants over the last three years have remained mild or milder.' He also noted that many infections now go undetected but still contribute to building antibody responses in the population, a natural form of immunization that limits severe illness. The testing levels have declined, and comprehensive data on current infections remains limited. 'Presently, there is no very good record of the number of tests being done, and it needs to be done scientifically. But there are no significant adverse clinical symptoms to be concerned about,' one senior DBT scientist said. Dr Rajeev Jayadevan, public health expert and past president of the Indian Medical Association (IMA), Cochin, said that Covid-19 is now behaving like a cyclical disease, with temporary immunity leading to periodic rises in cases. 'As the level of immunity in the population drops, the virus is able to infect more people and cases will naturally rise. However, due to past vaccination and exposure to the virus earlier, immune memory protects against severe disease and death,' he said. Vulnerable individuals, he added, should remain cautious, especially during periods of surge. Jayadevan also pointed out that SARS-CoV-2 continues to evolve in response to the human immune system, leading to recurring infection cycles roughly every 6 to 12 months. 'The reported number of cases is always an underestimate because of limited testing,' he said. Influenza, which is also circulating, remains a significant contributor to disease burden, he added. Earlier, Mint reported that a spike in cases during April was driven by the JN.1.16 sub-variant of Omicron. In May, most cases were linked to recombinant sub-lineages such as LF.7 and LP.8.1.2. As per government guidelines, all hospitalized Severe Acute Respiratory Illness (SARI) patients and 5% of Influenza Like Illness (ILI) cases continue to be tested for Covid-19. Positive SARI samples are routinely sent for genome sequencing. The health ministry reported 1,197 recoveries in the past 24 hours, bringing total recoveries this year to 19,435. Authorities continue to advise precautions, including avoiding crowded places when unwell and following Covid-appropriate behaviour. 'In hospitals too, patient load has come down and most cases are now manageable at home,' said Dr Vikas Maurya, head of the respiratory department at Fortis Hospital, Shalimar Bagh.